David P. Meeker
President and CEO at Rhythm Pharmaceuticals Inc.
Sits on 4 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 4
- Current seats
- 4
- Board service
- 8 years
- Director since
- 2023
8 years of board service in total across 4 boards, counting each seat separately. Longest: Rhythm Pharmaceuticals Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Rhythm Pharmaceuticals Inc. June 24, 202696.9%
-
Trevi Therapeutics Inc. June 13, 202471.6%
-
Rhythm Pharmaceuticals Inc. June 21, 202396.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 14, 2026 | Rhythm Pharmaceuticals Inc. | Option exercise | +50,000 | $6.05 | $302,500 |
| Sep 14, 2026 | Rhythm Pharmaceuticals Inc. | Open-market sale | −6,439 | $101.75 | $655,168 |
| Sep 14, 2026 | Rhythm Pharmaceuticals Inc. | Open-market sale | −30,746 | $102.35 | $3,146,853 |
| Sep 14, 2026 | Rhythm Pharmaceuticals Inc. | Open-market sale | −8,698 | $103.43 | $899,634 |
| Sep 14, 2026 | Rhythm Pharmaceuticals Inc. | Open-market sale | −1,817 | $104.55 | $189,967 |
| Sep 14, 2026 | Rhythm Pharmaceuticals Inc. | Open-market sale | −2,300 | $105.19 | $241,937 |
| Jun 17, 2026 | Kardigan Inc. | Grant or award | +20,706 | — | — |
| Feb 1, 2026 | Rhythm Pharmaceuticals Inc. | Option exercise | +68,713 | — | — |
| Feb 1, 2026 | Rhythm Pharmaceuticals Inc. | Shares withheld for tax | −31,522 | $108.99 | $3,435,583 |
| Jun 3, 2025 | Rhythm Pharmaceuticals Inc. | Option exercise | +43,620 | $4.59 | $200,216 |
| Jun 3, 2025 | Rhythm Pharmaceuticals Inc. | Open-market sale | −43,346 | $65.04 | $2,819,224 |
| Jun 3, 2025 | Rhythm Pharmaceuticals Inc. | Open-market sale | −274 | $65.60 | $17,974 |
| Feb 19, 2025 | Rhythm Pharmaceuticals Inc. | Open-market sale | −9,896 | $57.22 | $566,249 |
| Feb 16, 2025 | Rhythm Pharmaceuticals Inc. | Option exercise | +21,250 | — | — |
| Feb 4, 2025 | Rhythm Pharmaceuticals Inc. | Open-market sale | −4,278 | $59.43 | $254,242 |
Questions about David P. Meeker
What boards is David P. Meeker on?
David P. Meeker sits on the boards of Kardigan Inc., Pharvaris N.V., Rhythm Pharmaceuticals Inc. and Trevi Therapeutics Inc.
What company is David P. Meeker the CEO of?
David P. Meeker is President and CEO of Rhythm Pharmaceuticals Inc.
How long has David P. Meeker served on boards?
Our records show at least 8 years of board service across 4 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.